Teorias causais, sintomas motores, sintomas não-motores, diagnóstico e tratamento da Doença de Parkinson: uma revisão bibliográfica
DOI:
https://doi.org/10.33448/rsd-v11i7.29762Palavras-chave:
Doença de Parkinson; Sintomas clínicos; Diagnóstico clínico; Levodopa; Ensino em Saúde.Resumo
A Doença de Parkinson (DP) apresenta-se na senescência, limitando o movimento e progredindo para demência, sendo assim a segunda doença neurodegenerativa no mundo relacionada a idade. Desse modo, esta revisão bibliográfica tem como objetivo reunir informações relevantes sobre a DP para direcionar novas abordagens científicas que favorecerão à aplicação clínica, e assim, a qualidade de vida dos pacientes da PD. Foram selecionados e analisados 80 estudos publicados nos últimos 20 anos em base de dados com descritores indexados. O resultado observado direciona para a compreensão de teorias causais, sintomas motores e não-motores, diagnóstico e tratamento. Concluiu-se que o estudo norteia, a partir das informações levantadas, novos estudos experimentais para a melhora da qualidade de vida de pacientes da DP.
Referências
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Chaudhuri, K. R. & Weintraub, D. (2021). Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7, 47. https://doi.org/10.1038/s41572-021-00280-3.
Abreu, G. M., Valença, D. C., Campos, M. Júnior, da Silva, C. P., Pereira, J. S., Araujo , Leite M. A., Rosso, A. L., Nicaretta, D. H., Vasconcellos, L.F., da Silva, D. J., Della Coletta, M. V., Dos Santos, J. M., Gonçalves, A. P., Santos-Rebouças, C. B. & Pimentel, M. M. (2016). Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil. Neurosci Lett. 635, 67-70. https://doi.org/10.1016/j.neulet.2016.10.040.
Albers, J. A., Chand, P. & Anch, A. M. (2017). Multifactorial sleep disturbance in Parkinson's disease. Sleep medicine. 35(41), 48. https://doi.org/10.1016/j.sleep.2017.03.026.
Alifirova, V. M., Zhukova, N. G., Zhukova, I. A., Latypova, A. V., Titova, M. A., Mironova, Y. S., Izhboldina, O. P., Nikitina, M. A. & Petrov, V. A. (2016). A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(11),174-179. https://doi.org/10.17116/jnevro2016116111174-179.
Amaro, E. JR. & Yamashita, H. (2001). Aspectos básicos de tomografia Aspectos básicos de tomografia computadorizada e ressonância computadorizada e ressonância, magnética. Rev Bras Psiquiatr. 23(1), 2-3. https://doi.org/10.1590/S1516-44462001000500002.
Barbosa, E. R. & Sallem, F. A. S. (2005). Parkinson´s Disease – Diagnosis. Rev Neurociencias, 13(3), 158-165. https://doi.org/10.34024/rnc.2005.v13.8827.
Beitz, J. M. (2014). Parkinson's disease: a review. Frontiers in bioscience. 6(1), 65-74. https://doi.org/10.2741/s415.
Benadiba, M., Luurtsema, G., Wichert-Ana, L., Buchpigel, C. A. & Filho, G. B. (2012). New molecular targets for PET and SPECT imaging in neurodegenerative diseases. Revista Brasileira de Psiquiatria. 34(2), s125-s148. https://doi.org/10.1016/j.rbp.2012.08.002.
Berg, D., Postuma, R. B., Bloem, B., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Hardy, J., Lang, A. E., Litvan, I., Marek, K., Obeso, J., Oertel, W., Olanow, C. W., Poewe ,W., Stern, M. & Deuschl, G. (2014). Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society. 29(4), 454-62. https://doi.org/10.1002/mds.25844.
Berger, A. (2002). Magnetic resonance imaging. BMJ (Clinical research ed.), 324(7328), 35. https://doi.org/10.1136/bmj.324.7328.35.
Bose, A. & Beal, M. F. (2016). Mitochondria and Parkinson’s disease. J.Neurochem. 139 Suppl. 1, 216–231. https://doi.org/10.1111/jnc.13731.
Braak, H., Del Tredici, K., Rub, U., De Vos, R. A., Jansen Steur, E. N. & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging. 24(2), 197-211. https://doi.org/10.1016/s0197-4580(02)00065-9.
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H. & Del Tredici, K. (2004). Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318(1), 121-34. https://doi.org/10.1007/s00441-004-0956-9.
Burré, J., Sharma, M., & Südhof, T. C. (2018). Cell Biology and Pathophysiology of α-Synuclein. Cold Spring Harbor perspectives in medicine, 8(3), a024091. https://doi.org/10.1101/cshperspect.a024091.
Cedikova, M., Pitule, P., Kripnerova, M., Markova, M. & Kuncova, J. (2016). Multiple roles of mitochondria in aging processes. Physiological research. 65(Suppl 5), S519-S531. https://doi.org/10.33549/physiolres.933538.
Chung, S., Lee, E. J., Yun, S., Choe, H. K., Park, S. B., Son, H. J., Kim, K. S., Dluzen, D. E., Lee, I., Hwang, O., Son, G. H. & Kim, K. (2014). Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. Cell. 157(4), 858-68. https://doi.org/10.1016/j.cell.2014.03.039.
Deitos, M. V. & Trippo, K. V. (2017). Evaluation of posture image in Parkinson´s disease: A developmental study. Revista Pesquisa Em Fisioterapia, 7(4), 462–469. https://doi.org/10.17267/2238-2704rpf.v7i4.1569.
Díaz-Santos, M., Cao B., Yazdanbakhsh, A., Norton, D. J., Neargarder, S. & Cronin-Golomb, A. (2015). Perceptual, cognitive, and personality rigidity in Parkinson's disease. Neuropsychologia. 69, 183-93. https://doi.org/10.1016/j.neuropsychologia.2015.01.044.
Dirkx, M. F., Zach H., Bloem, B. R., Hallett, M. & Helmich, R. C. (2018). The nature of postural tremor in Parkinson disease. Neurology. 90(13), e1095-e1103. https://doi.org/10.1212/WNL.0000000000005215.
Falup-Pecurariu & Diaconu, Ş. (2017). Sleep Dysfunction in Parkinson's Disease. Int Rev Neurobiol. 133, 719-742. https://doi.org/10.1016/bs.irn.2017.05.033.
Fields, J. A. (2017). Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias. Arch Clin Neuropsychol. 32(7), 786-801. https://doi.org/10.1093/arclin/acx085.
Fois, A. F., Briceño, H. M., Fung, V. S. C. (2017). Nonmotor Symptoms in Essential Tremor and Other Tremor Disorders. Int Rev Neurobiol. 134, 1373-1396. https://doi.org/10.1016/bs.irn.2017.05.010.
Foley, J. A., Foltynie, T., Zrinzo, L., Hyam, J. A., Limousin, P., & Cipolotti, L. (2017). Apathy and reduced speed of processing underlie decline in verbal fluency following DBS. Behav. Neurol. 2017, 7348101. https://doi.org/10.1155/2017/7348101.
Frenkel-Toledo, S., Giladi, N., Peretz, C., Herman, T., Gruendlinger, L. & Hausdorff, J. M. (2005). Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson’s disease. Mov Disord, 20(9), 1109-1114. https://doi.org/10.1002/mds.20507.
Fukunaga, J. Y., Quitschal, R. M., Doná, F., Ferraz, H. B., Ganança, M. M. & Caovilla, H. H. (2014). Postural control in Parkinson’s disease. Braz J Otorhinolaryngol. 80(6), 508-14. https://doi.org/10.1016/j.bjorl.2014.05.032.
Gironell, A., Pascual-Sedano, B., Aracil, I., Marín-Lahoz, J., Pagonabarraga, J., & Kulisevsky, J. (2018). Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification. Parkinson's disease. 2018, 4327597. https://doi.org/10.1155/2018/4327597.
Glover, G. H. (2011). Overview of functional magnetic resonance imaging. Neurosurgery clinics of North America, 22(2), 133–vii. https://doi.org/10.1016/j.nec.2010.11.001.
Gövert F., Becktepe J. & Deuschl G. (2018). The new tremor classification of the International Parkinson and Movement Disorder Society: Update on frequent tremors. Nervenarzt. 89(4), 376-385. https://doi.org/10.1007/s00115-018-0489-1.
Graebner, A. K., Tarsy, D., Shih, L. C., Vanderhorst, V., Kulkarni, O., Kaplan, S. & Simon, D. K. (2017). Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center. Neurodegenerative diseases. 17(1), 38-43. https://doi.org/10.1159/000447561.
Haehner, A., Hummel, T. & Reichmann, H. (2014). A clinical approach towards smell loss in Parkinson's disease. Journal of Parkinson's disease. 4(2), 189-95. https://doi.org/10.3233/JPD-130278.
Hawkes, C. H., Del Tredici, K. & Braak, H. (2007). Parkinson's disease: a dual-hit hypothesis. Neuropathology and applied neurobiology. 33(6), 599-614. https://doi.org/10.1111/j.1365-2990.2007.00874.x.
Heim, B., Krismer, F., De Marzi, R. & Seppi, K. (2017). Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna). 124(8), 915-964. https://doi.org/10.1007/s00702-017-1717-8.
Heremans, E., Nackaerts, E., Vervoort, G., Broeder, S., Swinnen, S. P., & Nieuwboer, A. (2016). Impaired Retention of Motor Learning of Writing Skills in Patients with Parkinson's Disease with Freezing of Gait. PloS one, 11(2), e0148933. https://doi.org/10.1371/journal.pone.014893.
Högl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., Trenkwalder, C., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Schrag, A. & Goetz, C. G. (2010). Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord. 25(16), 2704-16. https://doi.org/10.1002/mds.23190.
Janiri, D., Petracca, M., Moccia, L., Tricoli, L., Piano, C., Bove, F., Imbimbo, I., Simonetti, A., Di Nicola, M., Sani, G., Calabresi, P. & Bentivoglio, A. R. (2020). COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly. Frontiers in psychiatry, 11, 581144. https://doi.org/10.3389/fpsyt.2020.581144.
Jiao, Z., Zhang, W., Chen, C., Zhu, X., Chen, X., Zhou, M., Peng, G., Liu, H., Qiu, J., Lin, Y., Huang, S., Mo, M., Yang, X., Qu, S. & Xu, P. (2019). Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson's Disease. ACS Chem Neurosci. 10(2), 803-811. https://doi.org/10.1021/acschemneuro.8b00373.
Jost, W. H. (2017). Autonomic Dysfunction in Parkinson's disease: Cardiovascular Symptoms, Thermoregulation, and Urogenital Symptoms. Int Rev Neurobiol. 134, 771-785. https://doi.org/10.1016/bs.irn.2017.04.003.
Kim, J., Jang, S., Choe, H. K., Chung, S., Son, G. H. & Kim, K. (2017). Implications of Circadian Rhythm in Dopamine and Mood Regulation. Molecules and cells. 40(7), 450-456. https://doi.org/10.14348/molcells.2017.0065.
Kwok, J. Y. Y., Smith, R., Chan, L. M. L., Lam, L. C. C., Fong, D. Y. T., Choi, E. P. H., Lok, K. Y. W., Lee, J. J., Auyeung, M. & Bloem, B. R. (2022). Managing freezing of gait in Parkinson's disease: a systematic review and network meta-analysis. J Neurol, 10.1007/s00415-022-11031-z. Advance online publication. https://doi.org/10.1007/s00415-022-11031-z.
Lee, T. K. & Yankee, E. L. (2021). A review on Parkinson’s disease treatment. Neuroimunol Neuroinflamation, 8, 222. https://doi.org/10.20517/2347-8659.2020.58
Lill, C. M. (2016). Genetics of Parkinson's disease. Molecular and cellular probes, 30(6), 386–396. https://doi.org/10.1016/j.mcp.2016.11.001.
Lima, M. S., Mangilli, L. D., Sassi, F. C. & Andrade, C. R. F. (2015). Functional magnetic resonance and swallowing: critical literature review. Braz J Otorhinolaryngol. 81(6), 671-680. https://doi.org/10.1016/j.bjorl.2015.08.006.
Lopes, M. S., Melo, A. S., Corona, A. P. & Nóbrega, A. C. (2018). Is there auditory impairment in parkinson’s disease? REV. CEFAC. 20(5), 573-582. https://doi.org/ 10.1590/1982-021620182052418.
Lotankar, S., Prabhavalkar, K. S. & Bhatt, L. K. (2017). Biomarkers for Parkinson's Disease: Recent Advancement. Neuroscience bulletin. 33(5), 585-597. https://doi.org/10.1007/s12264-017-0183-5.
Lozano, C. S., Tam, J., & Lozano, A. M. (2018). The changing landscape of surgery for Parkinson’s disease. Mov. Disord. 33(1), 36–47. https://doi.org/10.1002/mds.27228.
Lunati, A., Lesage, S. & Brice, A. (2018). The genetic landscape of Parkinson's disease. Rev Neurol (Paris). 174(9), 628-643. https://doi.org/10.1016/j.neurol.2018.08.004.
Magalhães, F., Rocha, K., Marinho, V., Ribeiro, J., Oliveira, T., Ayres, C., Bento, T., Leite, F., Gupta, D., Bastos, V. H., Velasques, B., Ribeiro, P., Orsini, M. & Teixeira, S. (2018). Neurochemical changes in basal ganglia affect time perception in parkinsonians. Journal of biomedical science. 25(1), 26. https://doi.org/10.1186/s12929-018-0428-2.
McDermott, K. L., Fisher, N., Bradford, S. & Camicioli, R. (2017). Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms. Int Psychogeriatr. 30(2), 253-260. https://doi.org/10.1017/S1041610217002265.
McKeith, I. G., Ferman, T. J., Thomas, A. J., Blanc, F., Boeve, B. F., Fujishiro, H., Kantarci, K., Muscio, C., O'Brien, J. T., Postuma, R. B., Aarsland, D., Ballard, C., Bonanni, L., Donaghy, P., Emre, M., Galvin, J. E., Galasko, D., Goldman, J. G., Gomperts, S. N., Honig, L. S., Ikeda, M., Leverenz, J. B., Lewis, S. J. G., Marder, K. S., Masellis, M., Salmon, D. P., Taylor, J. P., Tsuang, D. W., Walker, Z. & Tiraboschi, P. (2020). Diagnostic Study Group. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 94(17), 743-755. https://doi.org/10.1212/WNL.0000000000009323.
Mcnamara, P. (2011). The Cognitive Neuropsychiatry of Parkinson’s Disease. The Massachusetts Institute of Technology Press, 87–109.
Mercuri, N. B. & Bernardi, G. (2005). The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci. 26(7), 341-344. https://doi.org/10.1016/j.tips.2005.05.002.
Mikami, K., Shiraishi, M., Kawasaki, T. & Kamo, T. (2017). Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position. Plos One. 12(7), e0181210. https://doi.org/10.1371/journal.pone.0181210.
Ming, W., Palidis, D. J., Spering, M. & Mckeown, M. J. (2016). Visual contrast sensitivity in early-stage Parkinson’s disease. Investigative Ophthalmology & Visual Science. 57, 5696–5704. https://doi.org/10.1167/iovs.16-20025.
Moon, H. E. & Paek, S. H. (2015). Mitochondrial Dysfunction in Parkinson's Disease. Exp Neurobiol. 24(2), 103-16. https://doi.org/10.5607/en.2015.24.2.103.
Mulak, A. & Bonaz, B. (2015). Brain-gut-microbiota axis in Parkinson's disease. World journal of gastroenterology. 21(37), 10609–10620. https://doi.org/10.3748/wjg.v21.i37.10609.
Noyce, A. J., Dickson, J., Rees, R. N., Bestwick, J. P., Isaias, I. U., Politis, M., Giovannoni, G., Warner, T. T., Lees, A. J. & Schrag, A. (2018). Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease. Movement Disorders, 33(3), 478-482. https://doi.org/10.1002/mds.27282.
Nuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Teo, W. P., Hendy, A. M. & Macpherson, H. (2022). To the Gut Microbiome and Beyond: The Brain-First or Body-First Hypothesis in Parkinson's Disease. Front Microbiol. 13, 791213. https://doi.org/10.3389/fmicb.2022.791213.
Pfeiffer, R. F. (2020). Autonomic Dysfunction in Parkinson's Disease. Neurotherapeutics. 17(4), 1464-1479. https://doi.org/10.1007/s13311-020-00897-4.
Pikstra, A. R. A., Van Der Hoorn, A., Leenders, K. L. & De Jong, B. M. (2016). Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson's disease. NeuroImage Clinical. 11, 68-72. https://doi.org/10.1016/j.nicl.2016.01.010.
Politis, M., Pagano, G. & Niccolini, F. (2017). Imaging in Parkinson's Disease. International review of neurobiology. 132, 233-274. https://doi.org/10.1016/bs.irn.2017.02.015.
Reichmann, H. (2017). Premotor Diagnosis of Parkinson's Disease. Neuroscience bulletin. 33(5), 526-534. https://doi.org/10.1007/s12264-017-0159-5.
Rhodes, C. J. (2017). Magnetic resonance spectroscopy. Science Progress. 241-292. https://doi.org/10.3184/003685017X14993478654307.
Ridder, A., Müller, M. L., Kotagal, V., Frey, K. A., Albin, R. L. & Bohnen, N. I. (2017). Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & Related disorders. 34, 15-19. https://doi.org/10.1016/j.parkreldis.2016.10.006.
Rodríguez-Violante, M., Zerón-Martínez, R., Cervantes-Arriaga, A. & Corona, T. (2017). Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms. Arch Med Res. 48(3), 221-227. https://doi.org/10.1016/j.arcmed.2017.08.005.
Seifert, K. D. & Wiener, J. I. (2013). The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study. American journal of neurodegenerative disease. 2(1), 29–34.
Sharma, M., Naik, V. & Deogaonkar, M. (2016). Emerging applications of deep brain stimulation. J. Neurosurg. Sci. 60(2), 242–255.
Simon, D. K., Tanner, C. M. & Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 36(1), 1-12. https://doi.org/10.1016/j.cger.2019.08.002. https://doi.org/10.1016/j.cger.2019.08.002.
Sousa, A. S., Oliveira, S. O., Alves, L H. (2021). A Pesquisa Bibliográfica: Princípios e Fundamentos. Cadernos da Fucamp, 20(43), 64-83.
Stojkovska, I., Wagner, B. M., & Morrison, B. E. (2015). Parkinson's disease and enhanced inflammatory response. Experimental biology and medicine (Maywood, N.J.), 240(11), 1387–1395. https://doi.org/10.1177/1535370215576313.
Sung, S., Vijiaratnam, N., Chan, D. W. C., Farrell, M. & Evans, A. H. (2018). Parkinson disease: A systemic review of pain sensitivities and its association with clinical pain and response to dopaminergic stimulation. Journal of the neurological sciences. 395, 172-206. https://doi.org/10.1016/j.jns.2018.10.013.
Sveinbjornsdottir, S. (2016). The clinical symptoms of Parkinson's disease. J Neurochem. 139 Suppl 1, 318–324. https://doi.org/10.1111/jnc.13691.
Targa, A. D., Rodrigues, L. S., Noseda, A. C., Aurich, M. F., Andersen, M. L., Tufik, S., da Cunha, C. & Lima, M. M. (2016). Unraveling a new circuitry for sleep regulation in Parkinson's disease. Neuropharmacology. 108, 161-71. https://doi.org/10.1016/j.neuropharm.2016.04.018.
Timpka, J., Fox, T., Fox, K., Honig, H., Odin, P. & Martinez-Martin, P. (2016). Improvement of dyskinesias with L-dopa infusion in advanced Parkinson’s disease. Acta Neurol. Scand. 133, 451–458. https://doi.org/10.1111/ane.12483.
Tokushige, S. I., Terao, Y., Matsuda, S., Furubayashi, T., Sasaki, T., Inomata-Terada S., Yugeta A., Hamada, M., Tsuji, S. & Ugawa, Y. (2018). Does the Clock Tick Slower or Faster in Parkinson's Disease? Insights Gained from the Synchronized Tapping Task. Frontiers in psychology. 11(9), 1178. https://doi.org/10.3389/fpsyg.2018.01178.
Vázquez-Vélez, G. E., & Zoghbi, H. Y. (2021). Parkinson's Disease Genetics and Pathophysiology. Annual review of neuroscience, 44, 87–108. https://doi.org/10.1146/annurev-neuro-100720-034518
Vercruysse, S., Gilat, M., Shine, J. M., Heremans, E., Lewis, S. & Nieuwboer, A. (2014). Freezing beyond gait in Parkinson's disease: a review of current neurobehavioral evidence. Neurosci Biobehav Rev. 43, 213-27. https://doi.org/10.1016/j.neubiorev.2014.04.010.
Wang, G., Xie, H., Hou, S., Chen, W., Zhao, Q. & Li, S. (2015). Development of the 1.2 T~1.5 T Permanent Magnetic Resonance Imaging Device and Its Application for Mouse Imaging. BioMed research international. 2015, 858694. https://doi.org/10.1155/2015/858694.
World Health Organization (WHO) (2022). Mental health and COVID-19: Early evidence of the pandemic’s impact. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1
Yan, F., Chen, Y., Li, M., Wang, Y., Zhang, W., Chen, X. & Ye, Q. (2018). Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease. Medicine (Baltimore). 97(28), e11337. https://doi.org/10.1097/MD.0000000000011337.
Yoshii, F., Moriya, Y., Ohnuki, T., Ryo, M. & Takahashi, W. (2016). Postural deformities in Parkinson's disease - Mutual relationships among neck flexion, fore-bent, knee-bent and lateral-bent angles and correlations with clinical predictors. J Clin Mov Disord. 3, 1. https://doi.org/10.1186/s40734-016-0029-8.
Zhou, H., Arias-Ramos, N., López-Larrubia, P., Mason, R. P., Cerdán, S. & Pacheco-Torres, J. (2018). Oxygenation Imaging by Nuclear Magnetic Resonance Methods. Methods in molecular biology. 1718, 297-313. https://doi.org/10.1007/978-1-4939-7531-0_18.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 Francisco Magalhães; Valécia Natália Carvalho da Carvalho; Jacks Renan Neves Fernandes; Antonio Thomaz de Oliveira; Thayaná Ribeiro Silva Fernandes ; Silmar Teixeira
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
1) Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
2) Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
3) Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado.
